Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXO7FP
|
||||
| Drug Name |
(S)-2-(7-chlorobenzo[d]oxazol-2-ylamino)-3-cyclohexyl-N-(2-(4-fluorophenylamino)ethyl)propanamide
|
||||
| Synonyms |
CHEMBL204791
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H28ClFN4O2
|
||||
| Canonical SMILES |
Fc1ccc(NCCNC(=O)[C@H](CC2CCCCC2)Nc3oc4c(Cl)cccc4n3)cc1
|
||||
| InChI |
InChI=1S/C24H28ClFN4O2/c25-19-7-4-8-20-22(19)32-24(29-20)30-21(15-16-5-2-1-3-6-16)23(31)28-14-13-27-18-11-9-17(26)10-12-18/h4,7-12,16,21,27H,1-3,5-6,13-15H2,(H,28,31)(H,29,30)/t21-/m0/s1
|
||||
| InChIKey |
QGJDTIUIQQOWOY-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.